Package 69097-994-02

{"route": ["ORAL"], "spl_id": "8e10fac2-bb4b-4d93-ad8c-4fd93278a91e", "openfda": {"unii": ["OLH94387TE"], "rxcui": ["830874", "830877", "830879", "830882", "830897", "830900"], "spl_set_id": ["bce61158-201d-458c-be0c-9bdd2d3a0bec"], "manufacturer_name": ["Cipla USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-994-02)", "package_ndc": "69097-994-02", "marketing_start_date": "20230612"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-994-05)", "package_ndc": "69097-994-05", "marketing_start_date": "20230612"}], "brand_name": "DILTIAZEM HYDROCHLORIDE", "product_id": "69097-994_8e10fac2-bb4b-4d93-ad8c-4fd93278a91e", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A4 Inhibitors [MoA]"], "product_ndc": "69097-994", "generic_name": "diltiazem hydrochloride", "labeler_name": "Cipla USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DILTIAZEM HYDROCHLORIDE", "active_ingredients": [{"name": "DILTIAZEM HYDROCHLORIDE", "strength": "240 mg/1"}], "application_number": "ANDA216327", "marketing_category": "ANDA", "marketing_start_date": "20230612", "listing_expiration_date": "20261231"}